Damages of Cardiovascular System at Mucopolysaccharidosis Type I: Clinical Cases
Open Access
- 5 January 2020
- journal article
- research article
- Published by Paediatrician Publishers LLC in Current Pediatrics
- Vol. 18 (5) , 346-353
Abstract
Поражение сердечно-сосудистой системы при мукополисахаридозе I типа: клинические случаиKeywords
This publication has 7 references indexed in Scilit:
- Early diagnosis and management of cardiac manifestations in mucopolysaccharidoses: a practical guide for paediatric and adult cardiologistsItalian Journal of Pediatrics, 2018
- Il cardiologo e le mucopolisaccaridosi. Raccomandazioni del GICEM (Gruppo Italiano Cardiologi Esperti Malattie Metaboliche) su diagnosi, follow-up e management cardiologicoGiornale Italiano di Cardiologia, 2017
- Molecular Basis, Diagnosis and Clinical Management of MucopolysaccharidosesCardiogenetics, 2013
- Management of mucopolysaccharidosis type IH (Hurler's syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution's experienceJournal of Inherited Metabolic Disease, 2012
- Clear cells in the atrioventricular valves of infants with severe human mucopolysaccharidosis (Hurler syndrome) are activated valvular interstitial cellsCardiovascular Pathology, 2011
- Successful treatment of severe heart failure in an infant with Hurler syndromeJournal of Inherited Metabolic Disease, 2007
- Enzyme Replacement Therapy in Patients Who Have Mucopolysaccharidosis I and Are Younger Than 5 Years: Results of a Multinational Study of Recombinant Human α-l-Iduronidase (Laronidase)Pediatrics, 2007